AU: Commercial cultivation commenced at newly constructed greenhouse

Commercial cultivation has now officially commenced at Cann’s newly constructed state-of-the-art glasshouse in Mildura. Since receiving the required permits from the Office of Drug Control in March, Cann has been proceeding with the transfer of genetic material from its Southern facility, culminating in the transplantation of the first commercial crop
being completed yesterday. Approximately 4,000 cuttings were propagated in the Southern facility and transferred to Mildura for their vegetative growth phase prior to moving into the flowering room. This crop is expected to be harvested in June of this year


Left: a Cann employee tends mother plants at the facility, and right, the specialised misting system at work 

Cann has also completed its first GMP release of dried flower products from its Southern facility in Melbourne. These products were all cultivated, harvested, packaged and released from Cann’s GMP facility, which was recently licensed by the Therapeutic Goods
Administration. Demand for the dried flower product form remains high and Cann has increased production of its high THC cultivars to help meet this demand. Cann is well placed to increase the volume of this product form, with the aim of gaining greater market share.


Some of the first commercial crop which has just been transplanted in to Cann's Mildura facility

Finally, the company is pleased to report that Satipharm CBD capsules are now being manufactured at the Mildura facility, in support of the S3 registration program for this product.

Cann’s Chief Operating Officer, Shane Duncan, said “With our Mildura facility now coming online, it is pleasing to see the company move to producing medicinal cannabis products at scale. Work is continuing in Mildura with the installation and commissioning of table automation and processing systems as the first commercial crop goes through vegetative and flowering stages over the coming weeks.”